Search Results - "Mulligan, R C"

Refine Results
  1. 1

    Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D by RODINO-KLAPAC, L. R, LEE, J.-S, MULLIGAN, R. C, CLARK, K. R, MENDELL, J. R

    Published in Neurology (22-07-2008)
    “…Alpha-sarcoglycan (alpha-SG) deficiency (limb-girdle muscular dystrophy [LGMD] type 2D) is the most common form of sarcoglycan-LGMD. No treatment is currently…”
    Get full text
    Journal Article
  2. 2

    Dystrophin expression in the mdx mouse restored by stem cell transplantation by Kunkel, Louis M, Mulligan, Richard C, Gussoni, Emanuela, Soneoka, Yuko, Strickland, Corinne D, Buzney, Elizabeth A, Khan, Mohamed K, Flint, Alan F

    Published in Nature (London) (23-09-1999)
    “…The development of cell or gene therapies for diseases involving cells that are widely distributed throughout the body has been severely hampered by the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene by KARAPLIS, A. C, LUZ, A, GLOWACKI, J, BRONSON, R. T, TYBULEWICZ, V. L. J, KRONENBERG, H. M, MULLIGAN, R. C

    Published in Genes & development (01-02-1994)
    “…The parathyroid hormone-related peptide (PTHrP) gene was disrupted in murine embryonic stem cells by homologous recombination, and the null allele was…”
    Get full text
    Journal Article
  5. 5

    A Stable Human-Derived Packaging Cell Line for Production of High Titer Retrovirus/Vesicular Stomatitis Virus G Pseudotypes by Ory, Daniel S., Neugeboren, Beverly A., Mulligan, Richard C.

    “…We have generated a human 293-derived retroviral packaging cell line (293GPG) capable of producing high titers of recombinant Moloney murine leukemia virus…”
    Get full text
    Journal Article
  6. 6

    Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites by Lantz, Chris S, Boesiger, Jurg, Song, Chang Ho, Mach, Nicolas, Kobayashi, Takahiko, Mulligan, Richard C, Nawa, Yukifumi, Dranoff, Glenn, Galli, Stephen J

    Published in Nature (London) (05-03-1998)
    “…The cytokine interleukin-3 (IL-3), which can be derived from T cells and other sources, is a potentially important link between the immune and haematopoietic…”
    Get full text
    Journal Article
  7. 7

    Plasmid DNA encapsulation and release from solvent diffusion nanospheres by Hirosue, S, Müller, B.G, Mulligan, R.C, Langer, R

    Published in Journal of controlled release (29-01-2001)
    “…The first step toward hydrophobic polymer-based nanospheres for gene delivery is to encapsulate and release plasmid DNA. However, encapsulating large…”
    Get full text
    Journal Article
  8. 8

    Safe and Efficient Generation of Recombinant Retroviruses with Amphotropic and Ecotropic Host Ranges by Danos, Olivier, Mulligan, Richard C.

    “…We have constructed a set of packaging cell lines useful for the generation of helper-free recombinant retroviruses with amphotropic and ecotropic host ranges…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Effects of Retroviral Vector Design on Expression of Human Adenosine Deaminase in Murine Bone Marrow Transplant Recipients Engrafted with Genetically Modified Cells by Riviere, Isabelle, Brose, Katja, Mulligan, Richard C.

    “…To determine which features of retroviral vector design most critically affect gene expression in hematopoietic cells in vivo, we have constructed a variety of…”
    Get full text
    Journal Article
  12. 12

    Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation by Ikegami, M, Ueda, T, Hull, W, Whitsett, J A, Mulligan, R C, Dranoff, G, Jobe, A H

    Published in The American journal of physiology (01-04-1996)
    “…Mice made granulocyte macrophage-colony stimulating factor (GM-CSF)-deficient by homologous recombination maintain normal steady-state hematopoiesis but have…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Gene therapy to target dendritic cells from blood to lymph nodes by ROBERT, C, KLEIN, C, CHENG, G, KOGAN, A, MULLIGAN, R. C, VON ANDRIAN, U. H, KUPPER, T. S

    Published in Gene therapy (01-08-2003)
    “…Peripheral lymph nodes (PLN) are strategic microenvironments where antigen-presenting dendritic cells (DC), loaded with environmental antigens, and naive…”
    Get full text
    Journal Article
  15. 15

    Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice by Huffman, J A, Hull, W M, Dranoff, G, Mulligan, R C, Whitsett, J A

    Published in The Journal of clinical investigation (01-02-1996)
    “…Mutation of the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene by homologous recombination caused alveolar proteinosis in mice. To further…”
    Get full text
    Journal Article
  16. 16

    Generation and characterization of urokinase receptor-deficient mice by Dewerchin, M, Nuffelen, A V, Wallays, G, Bouché, A, Moons, L, Carmeliet, P, Mulligan, R C, Collen, D

    Published in The Journal of clinical investigation (01-02-1996)
    “…Mice homozygously deficient for the urokinase-type plasminogen activator (u-PA) receptor (u-PAR-1-) were generated by homologous recombination in D3, embryonic…”
    Get full text
    Journal Article
  17. 17

    Demonstration that CFTR is a Chloride Channel by Alteration of its Anion Selectivity by Anderson, Matthew P., Gregory, Richard J., Thompson, Simon, Souza, David W., Paul, Sucharita, Mulligan, Richard C., Smith, Alan E., Welsh, Michael J.

    “…Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) generates adenosine 3′,5′-monophosphate (cAMP)-regulated chloride channels,…”
    Get full text
    Journal Article
  18. 18

    Demonstration of a rational strategy for human prostate cancer gene therapy by Sanda, M G, Ayyagari, S R, Jaffee, E M, Epstein, J I, Clift, S L, Cohen, L K, Dranoff, G, Pardoll, D M, Mulligan, R C, Simons, J W

    Published in The Journal of urology (01-03-1994)
    “…The potential efficacy and clinical feasibility of gene therapy for prostate cancer were tested. Efficacy was tested using the Dunning rat prostate carcinoma…”
    Get more information
    Journal Article
  19. 19

    Dispensable Sequence Motifs in the RAG-1 and RAG-2 Genes for Plasmid V(D)J Recombination by Silver, Daniel P., Spanopoulou, Eugenia, Mulligan, Richard C., Baltimore, David

    “…As a probe of whether RAG-1 and RAG-2 gene products activate other genes or form part of the recombinase itself, certain mutants of the RAG genes were assayed…”
    Get full text
    Journal Article
  20. 20

    Generation of a High-Titer Retroviral Vector Capable of Expressing High Levels of the Human β-Globin Gene by Sadelain, Michel, C. H. Jason Wang, Antoniou, Michael, Grosveld, Frank, Mulligan, Richard C.

    “…Retrovirus-mediated gene transfer into hematopoietic cells may provide a means of treating both inherited and acquired diseases involving hematopoietic cells…”
    Get full text
    Journal Article